NewHold Investment Corp IV Announces Pricing of $175 Million Initial Public Offering

Rhea-AI Summary

NewHold Investment Corp IV (NHIV) priced a $175.0 million initial public offering of 17,500,000 units at $10.00 per unit on April 14, 2026, with each unit containing one Class A ordinary share and one-third of a redeemable warrant.

Units begin trading on Nasdaq Global Market as NHIVU on April 15, 2026; Class A shares and warrants are expected to trade as NHIV and NHIVW after separation. The underwriter has a 45-day 15% over-allotment option to purchase up to 2,625,000 additional units. The offering is expected to close April 16, 2026.

Positive

• Initial cash raised: $175.0 million via 17,500,000 units
• Nasdaq listing: units to trade as NHIVU beginning April 15, 2026
• Underwriter over-allotment: 2,625,000-unit 45-day option (15%)

Negative

• Warrant exercise price $11.50 could dilute equity if exercised
• Units include one-third warrant each, creating potential future dilution upon separation

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

New York, New York, April 14, 2026 (GLOBE NEWSWIRE) --  NewHold Investment Corp IV (the “Company”), a newly organized special purpose acquisition company formed as a Cayman Islands exempted company, today announced the pricing of its initial public offering of 17,500,000 units at an offering price of $10.00 per unit, with each unit consisting of one Class A ordinary share and one-third of one redeemable warrant. Each whole warrant, which becomes exercisable 30 days after the completion of the Company’s initial business combination, will entitle the holder thereof to purchase one Class A ordinary share at $11.50 per share. The units are expected to trade on the Global Market tier of the Nasdaq Stock Market LLC (“Nasdaq”) under the ticker symbol “NHIVU” beginning April 15, 2026. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and the warrants are expected to be traded on Nasdaq under the symbols “NHIV” and “NHIVW,” respectively.

BTIG, LLC is acting as sole book-running manager for the offering.

The Company has granted the underwriter a 45-day option to purchase up to an additional 2,625,000 units at the initial public offering price to cover over-allotments, if any. The offering is expected to close on April 16, 2026, subject to customary closing conditions.

A registration statement relating to the securities sold in the initial public offering was declared effective by the U.S. Securities and Exchange Commission (the “SEC”) on April 14, 2026. The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained from: BTIG, LLC, 65 East 55th Street New York, New York 10022, or by email at ProspectusDelivery@btig.com, or by accessing the SEC’s website at www.sec.gov.

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About NewHold Investment Corp IV

NewHold Investment Corp IV is a blank check company, also commonly referred to as a special purpose acquisition company, or SPAC, formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. While the Company may pursue a business combination in any business, industry, sector or geographical location, the Company will primarily focus on growing industrial and business services companies. The Company is led by an experienced management team with Kevin Charlton as Chief Executive Officer, Samy Hammad as President and Chief Operating Officer and Polly Schneck as Chief Financial Officer.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the Company’s initial public offering (“IPO”) and search for an initial business combination. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of NewHold Investment Corp IV, including those set forth in the Risk Factors section of NewHold Investment Corp IV’s registration statement and preliminary prospectus for the IPO filed with the SEC. Copies are available on the SEC's website, www.sec.gov. NewHold Investment Corp IV undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Contacts:

Polly Schneck
Chief Financial Officer
pschneck@newholdllc.com

Investor & Media Contact:
Amanda Tarplin
amanda@tarplinconsulting.com

FAQ

What did NewHold Investment Corp IV (NHIV) price its IPO at and how many units were sold?

NewHold priced the offering at $10.00 per unit for 17,500,000 units. According to NewHold Investment Corp IV, each unit contains one Class A ordinary share and one-third of one redeemable warrant.

When will NHIV units and shares begin trading on Nasdaq and under which ticker symbols?

NHIV units are expected to start trading on Nasdaq Global Market as NHIVU on April 15, 2026. According to NewHold Investment Corp IV, separated Class A shares and warrants are expected to trade as NHIV and NHIVW.

What is the warrant structure and exercise price for NHIV units from the April 14, 2026 IPO?

Each unit includes one-third of a redeemable warrant; whole warrants are exercisable at $11.50 per share. According to NewHold Investment Corp IV, whole warrants become exercisable 30 days after the initial business combination.

Does NHIV’s offering include an over-allotment option and how large is it?

Yes — the underwriter has a 45-day option to purchase up to 2,625,000 additional units (15%). According to NewHold Investment Corp IV, this over-allotment covers potential over-allotments at the IPO price.

When is the NHIV IPO expected to close and what regulatory clearance was obtained?

The offering is expected to close on April 16, 2026, subject to customary conditions. According to NewHold Investment Corp IV, the registration statement was declared effective by the SEC on April 14, 2026.

How can investors obtain the NHIV prospectus after the April 14, 2026 pricing?

Investors can request the prospectus from BTIG by mail or email, or access it on the SEC website. According to NewHold Investment Corp IV, BTIG provides prospectus copies and the SEC’s www.sec.gov hosts the filing.